Artificial Ventilation Sales

Artificial Ventilation Sales Market Outlook

The global artificial ventilation sales market is projected to reach approximately USD 8 billion by 2035, expanding at a compound annual growth rate (CAGR) of around 6% during the forecast period of 2025 to 2035. This growth is primarily driven by increasing respiratory diseases, the rising geriatric population, and the growing prevalence of chronic obstructive pulmonary diseases (COPD) and sleep apnea. Additionally, the ongoing advancements in ventilation technology and the rising awareness of the importance of respiratory health are anticipated to contribute significantly to the market's expansion. Furthermore, the COVID-19 pandemic has heightened the demand for ventilators and respiratory care devices, making significant investments in healthcare infrastructure essential in many regions worldwide.

Growth Factor of the Market

Several key factors are fueling the growth of the artificial ventilation sales market. The surge in the incidence of respiratory disorders, including asthma, COPD, and acute respiratory distress syndrome (ARDS), has created a substantial demand for artificial ventilation solutions. Moreover, the increasing awareness about the importance of respiratory therapy and the availability of advanced ventilation technologies have significantly contributed to market growth. The shift towards home healthcare settings, where patients can receive ventilatory support in a comfortable environment, has also been a pivotal growth driver. Furthermore, government initiatives aimed at improving healthcare facilities and access, especially in developing nations, are expected to further amplify market demands. Lastly, the rise in emergency medical services (EMS) during health crises and disasters has necessitated the provision of portable ventilation solutions, thus enhancing the market's growth potential.

Key Highlights of the Market

• Projected global market size of USD 8 billion by 2035 with a CAGR of 6%.
• Increased prevalence of chronic respiratory diseases as a primary growth driver.
• Advancements in ventilation technology leading to enhanced patient outcomes.
• Growing preference for homecare settings for respiratory therapy.
• Government initiatives to improve healthcare access and facilities globally.

By Product Type

Ventilators:

Ventilators represent a significant segment of the artificial ventilation sales market, catering to patients who require respiratory support due to various medical conditions such as ARDS, pneumonia, or during surgical procedures. These devices can be categorized into invasive and non-invasive types, with invasive ventilators typically used in critical care settings, while non-invasive ventilators are employed in homecare settings and during clinical treatments. The advancement in technology has led to the development of portable and compact ventilators, enabling healthcare providers to offer efficient respiratory support in diverse settings, including ambulances and rural healthcare facilities. The COVID-19 pandemic has further intensified the demand for ventilators, prompting governments and institutions to stockpile these essential devices to prepare for future health crises. Consequently, this segment's growth is expected to remain robust in the coming years, primarily driven by technological innovations and the ongoing rise in respiratory illness prevalence.

Respiratory Masks:

Respiratory masks play a crucial role in artificial ventilation, providing essential support to patients who are unable to breathe adequately on their own. This product type includes various masks designed for different applications, such as CPAP (Continuous Positive Airway Pressure) masks for sleep apnea patients, non-rebreather masks for emergency use, and surgical masks for infection control in healthcare settings. The increasing awareness of respiratory health and the rising incidence of sleep-related disorders have fueled demand for respiratory masks in both clinical and homecare environments. Additionally, the development of more comfortable and effective mask designs has enhanced patient compliance and satisfaction, further driving market growth. The global emphasis on infection control, exacerbated by the COVID-19 pandemic, has also prompted the widespread use of respiratory masks, emphasizing their importance in providing adequate ventilation and ensuring patient safety.

Airway Management Devices:

Airway management devices are vital components in ensuring proper ventilation and oxygenation in patients, especially during emergencies or surgical procedures. This segment includes devices such as endotracheal tubes, laryngeal masks, and bag-mask devices that facilitate airway access and control. The increasing number of surgical procedures and emergencies requiring rapid airway management has significantly driven the demand for these devices. The growing emphasis on effective resuscitation practices and advancements in airway management technologies, such as video laryngoscopes, have further enhanced the safety and efficacy of airway interventions. As healthcare providers continue to prioritize patient-centered care and streamlined emergency responses, the airway management devices market is expected to exhibit considerable growth in the coming years, driven by technological innovations and an expanding patient population requiring effective respiratory care.

Oxygen Concentrators:

The demand for oxygen concentrators has surged significantly, primarily due to the rising incidence of respiratory diseases, particularly among the aging population. These devices are designed to deliver concentrated oxygen to patients who suffer from conditions such as COPD, asthma, or other chronic respiratory ailments. Oxygen concentrators are increasingly being utilized in homecare settings, allowing patients to receive continuous oxygen therapy in the comfort of their homes. This shift towards home-based care is being facilitated by technological advancements that have made oxygen concentrators more portable, efficient, and user-friendly. Furthermore, the pandemic highlighted the urgent need for supplemental oxygen in managing COVID-19 patients, which has catalyzed the growth of this product segment. With ongoing initiatives to improve healthcare access and the development of more compact and cost-effective devices, the oxygen concentrators market is expected to display robust growth over the forecast period.

Others:

This category includes a range of additional artificial ventilation products beyond the primary types mentioned above. These may include nebulizers, spirometers, and other respiratory therapy devices that support patient breathing and lung function. The demand for these ancillary products is driven by their critical role in comprehensive respiratory care, particularly in managing chronic respiratory diseases and facilitating pulmonary rehabilitation. As healthcare providers increasingly adopt a holistic approach to patient management, emphasizing integrated respiratory care, the market for these products is poised for growth. Additionally, the development of advanced technologies that enhance the effectiveness of these devices is expected to further contribute to their market expansion. The rising trend of personalized medicine, which tailors treatment to individual patient needs, will also play a crucial role in driving the sales of these diverse artificial ventilation products.

By Application

Hospitals:

Hospitals remain the largest application segment for artificial ventilation sales, as they cater to a wide range of patients requiring respiratory support due to acute and chronic conditions. The demand for advanced ventilators and respiratory devices in critical care units, emergency departments, and surgical settings is significant, driven by the need for timely and effective respiratory interventions. Hospitals are continually investing in upgrading their ventilation equipment to enhance patient outcomes and comply with safety and regulatory standards. Additionally, the COVID-19 pandemic has reinforced the critical need for well-equipped hospitals capable of managing respiratory illnesses, leading to an unprecedented surge in ventilator procurement. The growing focus on improving emergency response capabilities and the increasing prevalence of respiratory diseases are expected to sustain growth in this segment over the forecast period.

Clinics:

The clinic application segment of the artificial ventilation sales market is experiencing growth driven by the rising number of outpatient procedures and the increasing focus on preventive healthcare. Clinics, particularly those specializing in respiratory care and chronic disease management, are adopting effective ventilation solutions to provide quality treatment for patients with respiratory conditions. The advancement of portable ventilation technologies has made it feasible for clinics to offer efficient respiratory support without the need for extensive infrastructure. Moreover, an increasing emphasis on early diagnosis and treatment of respiratory diseases in clinical settings is fostering the demand for respiratory therapy devices. As healthcare systems continue to evolve towards integrated and patient-centered care models, the role of clinics in delivering effective ventilation solutions is expected to grow significantly.

Homecare Settings:

Homecare settings are witnessing a remarkable uptick in the adoption of artificial ventilation solutions, underscoring a notable shift towards providing care in patients' homes. With advancements in technology facilitating the development of compact and user-friendly respiratory devices, patients can now receive necessary ventilation support without the need for hospitalization. The increasing prevalence of chronic respiratory conditions among the aging population is a key growth driver in this segment, as many patients prefer to manage their health in a familiar environment. Additionally, the COVID-19 pandemic has catalyzed the acceptance and utilization of homecare treatments for respiratory ailments, further expanding the market. The emphasis on personalized healthcare and cost-effective treatment options is expected to propel the growth of artificial ventilation solutions in homecare settings in the coming years.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are gaining traction as an essential application area for artificial ventilation sales, largely due to their ability to provide efficient and safe surgical procedures in a cost-effective manner. The rising preference for outpatient surgeries, facilitated by advancements in minimally invasive surgical techniques, has led to increased demand for ventilation solutions that support anesthetic procedures. The availability of portable and versatile ventilators in ASCs allows healthcare providers to effectively manage patients' respiratory needs during and after surgery. Furthermore, the growing number of ASCs, driven by the rising surgical volume and patient convenience, is expected to bolster the market for artificial ventilation devices in this segment. As healthcare continues to evolve, the integration of advanced respiratory management technologies in ASCs will play a crucial role in enhancing patient outcomes and ensuring efficient surgical care.

Emergency Medical Services:

Emergency Medical Services (EMS) represent a critical application segment for artificial ventilation solutions, as they play a vital role in providing immediate respiratory support to patients in life-threatening situations. The demand for portable ventilators and bag-valve masks is substantial, as these devices are essential for maintaining airway patency and ensuring oxygenation during transportation. The increasing focus on improving emergency response times and protocols has heightened the importance of effective ventilation solutions in the EMS sector. Additionally, the rise in emergency medical calls, coupled with a growing emphasis on enhancing pre-hospital care, is driving the demand for innovative ventilation devices tailored for EMS applications. As advancements in technology continue to shape the landscape of pre-hospital care, the artificial ventilation market within EMS is expected to thrive over the forecast period.

By Distribution Channel

Hospitals & Clinics:

Hospitals and clinics serve as significant distribution channels for artificial ventilation products, as they cater directly to the needs of patients requiring respiratory support. These institutions are typically the primary purchasers of ventilators, masks, and other related devices, given their roles as healthcare providers where acute and chronic respiratory conditions are managed. The established relationships between hospitals and manufacturers facilitate efficient procurement processes, ensuring that healthcare facilities are equipped with the latest technology to improve patient outcomes. The growing focus on enhancing patient care and safety measures in hospital settings amplifies the demand for advanced ventilation solutions. Furthermore, with the increasing adoption of integrated healthcare systems, hospitals and clinics are better positioned to leverage technological advancements, thereby further boosting the sales of artificial ventilation products.

Retail Pharmacies:

Retail pharmacies have emerged as an important distribution channel for artificial ventilation solutions, particularly for homecare applications. As patients increasingly seek convenient access to respiratory therapy devices, retail pharmacies are expanding their offerings to include a range of ventilation products, including portable oxygen concentrators and respiratory masks. This segment is driven by the growing trend of self-management of chronic conditions, as patients prefer to purchase devices that can support their respiratory needs directly from pharmacies. The increasing consumer awareness of respiratory health and the availability of over-the-counter respiratory products have further catalyzed the growth of this distribution channel. Additionally, retail pharmacies provide valuable customer support and education, enabling patients to make informed decisions regarding their respiratory care needs.

Online Stores:

The online store distribution channel has gained significant momentum in the artificial ventilation sales market, providing patients and healthcare professionals with easy access to a variety of respiratory devices and accessories. The convenience of online shopping, coupled with the ability to compare products and prices, has made this channel increasingly popular among consumers. Additionally, the COVID-19 pandemic accelerated the adoption of e-commerce, as consumers sought contactless purchasing options for essential health products. Online platforms often offer a broader selection of ventilation devices, including advanced models that may not be readily available in physical stores. Furthermore, the growth of telemedicine and digital health solutions is expected to further enhance the demand for online sales of artificial ventilation products, as more patients seek remote consultations and treatment options.

Long-term Care Centers:

Long-term care centers, including nursing homes and rehabilitation facilities, represent a crucial distribution channel for artificial ventilation solutions, as they provide ongoing care to patients with chronic respiratory conditions. The demand for effective respiratory support in these settings is driven by the increasing number of elderly patients with complex health needs who require continuous monitoring and management. Long-term care centers often need a range of ventilation products, from portable oxygen devices to advanced ventilators, to accommodate the varying requirements of their residents. Additionally, the focus on enhancing the quality of care and improving patient outcomes in long-term care environments further amplifies the demand for artificial ventilation solutions. As the population ages, the role of long-term care centers in distributing ventilation products is expected to grow significantly in the coming years.

By Region

North America, particularly the United States, is anticipated to dominate the artificial ventilation sales market due to the high prevalence of chronic respiratory diseases, advanced healthcare infrastructure, and increased healthcare expenditure. The region is projected to maintain a significant market share, primarily driven by the rising demand for advanced ventilators and respiratory devices, especially following the COVID-19 pandemic. The presence of key manufacturers and their continuous innovations are also expected to contribute significantly to market growth. The North American market is forecasted to grow at a CAGR of approximately 5.5% during the forecast period, reflecting a robust demand for effective respiratory solutions in this region.

Europe is expected to hold the second-largest market share, driven by an increasing geriatric population and rising awareness regarding respiratory health. Countries such as Germany, France, and the UK are leading contributors to the European market, as they focus on enhancing healthcare facilities and implementing advanced ventilation technologies. The Asia Pacific region is also anticipated to experience substantial growth, fueled by rising healthcare investments, particularly in countries like China and India, where there is a growing demand for effective respiratory care solutions. The Latin America and Middle East & Africa regions, while smaller in comparison, are likely to witness growth as healthcare infrastructure improves and the prevalence of respiratory diseases rises.

Opportunities

The artificial ventilation sales market presents numerous opportunities that can be leveraged by stakeholders to achieve significant growth. One notable opportunity lies in the development of innovative ventilation technologies that cater to the diverse and evolving needs of patients. As healthcare systems increasingly prioritize personalized treatment, the demand for customizable ventilation solutions tailored to specific patient profiles is expected to rise. Moreover, the growing trend towards outpatient care and home healthcare is creating an expanding market for portable ventilation devices that enable patients to manage their respiratory health at home. Companies that focus on enhancing the user experience and improving the efficacy of their products can capitalize on this opportunity to attract new customers. Furthermore, partnerships and collaborations with healthcare institutions can aid manufacturers in gaining insights into patient needs and preferences, enabling the development of targeted products that meet market demands.

Another significant opportunity exists in emerging markets, where healthcare systems are evolving rapidly. With increasing investments in healthcare infrastructure and rising awareness of respiratory health, there is a growing demand for artificial ventilation solutions in countries such as India, Brazil, and South Africa. As these regions continue to urbanize and experience demographic shifts, the prevalence of chronic respiratory diseases is likely to rise, leading to a surge in demand for effective ventilation care. Manufacturers that strategically enter these markets can benefit from first-mover advantages and establish a strong presence in underserved regions. Additionally, government initiatives aimed at improving healthcare access and affordability can further bolster market opportunities by incentivizing the adoption of advanced respiratory technologies.

Threats

Despite the promising growth prospects of the artificial ventilation sales market, there are certain threats that stakeholders must navigate to maintain success. One of the primary threats is the increasing competition within the market, as numerous manufacturers and new entrants strive to capture market share. This heightened competition can result in pricing pressures, impacting profit margins and forcing companies to constantly innovate and differentiate their products. Additionally, regulatory challenges and stringent compliance requirements can pose barriers to entry for new players in the market. Navigating the complex regulatory landscape can be time-consuming and resource-intensive, potentially hindering the ability of companies to introduce new products and technologies. Furthermore, economic fluctuations and uncertainties can affect healthcare budgets and spending patterns, leading to reduced investments in artificial ventilation solutions.

Another significant threat is the potential for technological obsolescence, as rapid advancements in medical technology may render existing products outdated. Companies must continuously invest in research and development to stay ahead of technological trends and meet the evolving needs of healthcare providers and patients. Additionally, the growing emphasis on cost containment in healthcare may lead to increased scrutiny of expenditures on artificial ventilation solutions, forcing manufacturers to demonstrate clear value and efficacy. This shift in focus towards cost-effectiveness can create challenges for companies that may struggle to justify higher-priced advanced technologies. As the market landscape evolves, stakeholders must remain agile and responsive to external pressures to ensure sustained growth and competitiveness in the artificial ventilation sales market.

Competitor Outlook

• Philips Healthcare
• Medtronic
• GE Healthcare
• Hamilton Medical
• ResMed
• Smiths Medical
• Drägerwerk AG
• Invacare Corporation
• Vyaire Medical
• AirSep Corporation
• Fisher & Paykel Healthcare
• Cardinal Health
• Sunrise Medical
• OxySure Systems
• Getinge Group

The competitive landscape of the artificial ventilation sales market features a diverse array of established manufacturers and emerging players who are continuously striving to innovate and capture market share. Major companies such as Philips Healthcare, Medtronic, and GE Healthcare are at the forefront, leveraging their advanced technologies and expansive distribution networks to enhance their market positions. These industry leaders are investing significantly in research and development to introduce cutting-edge ventilation devices that address the evolving needs of healthcare providers and patients. Moreover, strategic partnerships and collaborations with healthcare institutions are being pursued to gain insights into customer preferences and refine product offerings, ultimately enabling these companies to maintain a competitive edge in the market.

Companies like ResMed and Hamilton Medical are also notable contenders in the market, specializing in advanced ventilation solutions and respiratory devices aimed at improving patient outcomes. ResMed, in particular, has established a strong presence in the homecare segment, focusing on the development of portable oxygen concentrators and non-invasive ventilation devices. Hamilton Medical is recognized for its innovative ventilatory support solutions that enhance patient safety and comfort. These companies continually seek to optimize their product lines and expand their market reach through strategic initiatives, including mergers and acquisitions, to strengthen their competitive positioning.

Additionally, emerging players and niche manufacturers are entering the artificial ventilation sales market, capitalizing on the growing demand for specialized ventilation solutions. Companies like Fisher & Paykel Healthcare and Drägerwerk AG are making significant strides in developing unique ventilation technologies tailored to specific clinical applications. These niche players often focus on enhancing patient-centered care and user-friendly designs, differentiating themselves from larger competitors. As the market evolves, the competition is expected to intensify, with companies continuously innovating and adapting to the changing landscape of artificial ventilation solutions to meet the diverse needs of patients and healthcare providers.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 ResMed
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 GE Healthcare
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Getinge Group
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Smiths Medical
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Vyaire Medical
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Cardinal Health
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 OxySure Systems
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Sunrise Medical
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Hamilton Medical
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 AirSep Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Philips Healthcare
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Drägerwerk AG
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Invacare Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Fisher & Paykel Healthcare
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Artificial Ventilation Sales Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Homecare Settings
    • 6.1.4 Ambulatory Surgical Centers
    • 6.1.5 Emergency Medical Services
  • 6.2 Artificial Ventilation Sales Market, By Product Type
    • 6.2.1 Ventilators
    • 6.2.2 Respiratory Masks
    • 6.2.3 Airway Management Devices
    • 6.2.4 Oxygen Concentrators
    • 6.2.5 Others
  • 6.3 Artificial Ventilation Sales Market, By Distribution Channel
    • 6.3.1 Hospitals & Clinics
    • 6.3.2 Retail Pharmacies
    • 6.3.3 Online Stores
    • 6.3.4 Long-term Care Centers
    • 6.3.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Artificial Ventilation Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Artificial Ventilation Sales market is categorized based on

By Product Type

• Ventilators
• Respiratory Masks
• Airway Management Devices
• Oxygen Concentrators
• Others

By Application

• Hospitals
• Clinics
• Homecare Settings
• Ambulatory Surgical Centers
• Emergency Medical Services

By Distribution Channel

• Hospitals & Clinics
• Retail Pharmacies
• Online Stores
• Long-term Care Centers
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Philips Healthcare
• Medtronic
• GE Healthcare
• Hamilton Medical
• ResMed
• Smiths Medical
• Drägerwerk AG
• Invacare Corporation
• Vyaire Medical
• AirSep Corporation
• Fisher & Paykel Healthcare
• Cardinal Health
• Sunrise Medical
• OxySure Systems
• Getinge Group